Quantcast

2D nanomaterials based electrochemical biosensors for cancer diagnosis

Research paper by Lu Wang, Qirong Xiong, Fei Xiao, Hongwei Duan

Indexed on: 14 Jun '16Published on: 07 Jun '16Published in: Biosensors and Bioelectronics



Abstract

Cancer is a leading cause of death in the world. Increasing evidence has demonstrated that early diagnosis holds the key towards effective treatment outcome. Cancer biomarkers are extensively used in oncology for cancer diagnosis and prognosis. Electrochemical sensors play key roles in current laboratory and clinical analysis of diverse chemical and biological targets. Recent development of functional nanomaterials offers new possibilities of improving the performance of electrochemical sensors. In particular, 2D nanomaterials have stimulated intense research due to their unique array of structural and chemical properties. The 2D materials of interest cover broadly across graphene, graphene derivatives (i.e., graphene oxide and reduced graphene oxide), and graphene-like nanomaterials (i.e., 2D layered transition metal dichalcogenides, graphite carbon nitride and boron nitride nanomaterials), In this review, we summarize recent advances in the synthesis of 2D nanomaterials and their applications in electrochemical biosensing of cancer biomarkers (nucleic acids, proteins and some small molecules), and present a personal perspective on the future direction of this area.

Figure 10.1016/j.bios.2016.06.011.0.jpg
Figure 10.1016/j.bios.2016.06.011.1.jpg
Figure 10.1016/j.bios.2016.06.011.2.jpg
Figure 10.1016/j.bios.2016.06.011.3.jpg
Figure 10.1016/j.bios.2016.06.011.4.jpg
Figure 10.1016/j.bios.2016.06.011.5.jpg
Figure 10.1016/j.bios.2016.06.011.6.jpg
Figure 10.1016/j.bios.2016.06.011.7.jpg